China Isotope & Radiation Corp
HKEX:1763
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
Market Cap | EV/EBIT | ||||
---|---|---|---|---|---|
CN |
C
|
China Isotope & Radiation Corp
HKEX:1763
|
3.5B HKD | 1.9 | |
JP |
Hoya Corp
TSE:7741
|
6.4T JPY | 28.9 | ||
CH |
Alcon AG
SIX:ALC
|
35.7B CHF | 36.3 | ||
DK |
Coloplast A/S
CSE:COLO B
|
193.7B DKK | 30.4 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
23.2B USD | 33.8 | ||
US |
Cooper Companies Inc
NYSE:COO
|
17.8B USD | 38.1 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
14.2T KRW | -113 | |
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
56.8B CNY | 29.9 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.3B GBP | 50.9 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
6.4B USD | 26.5 | ||
CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.2B USD | 44.1 |
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.